首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cold spring harbor perspectives in medicine

缩写:CSH PERSPECT MED

ISSN:2157-1422

e-ISSN:2157-1422

IF/分区:10.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1314
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mia J Smith,Joanne Boldison,F Susan Wong Mia J Smith
While autoreactive T cells are known to induce β-cell death in type 1 diabetes (T1D), self-reactive B cells also play an important role in the pathogenesis of T1D. Studies have shown that individuals living with T1D have an increased frequ...
Tae Gun Kang,Benjamin Youngblood Tae Gun Kang
Type 1 diabetes (T1D) serves as an exemplar of chronic autoimmune disease characterized by insulin deficiency due to pancreatic β-cell destruction, leading to hyperglycemia and progressive organ failure. Until recently, therapeutic efforts...
Irina Kusmartseva,Amanda Posgai,Mingder Yang et al. Irina Kusmartseva et al.
The Network for Pancreatic Organ Donors with Diabetes (nPOD) has helped shape the contemporary understanding of type 1 diabetes (T1D) pathogenesis in humans through the procurement, distribution to scientists, and collaborative study of hum...
Diane R Bielenberg,Patricia A D&#x;Amore Diane R Bielenberg
During development, the first blood vessels are formed by the de novo assembly of angioblasts, endothelial cell precursors, in a process called vasculogenesis. All subsequent sprouting of blood vessels from pre-existing vessels is termed an...
Timothy J Kieffer,Corinne A Hoesli,A M James Shapiro Timothy J Kieffer
β-Cell replacement for type 1 diabetes (T1D) can restore normal glucose homeostasis, thereby eliminating the need for exogenous insulin and halting the progression of diabetes complications. Success in achieving insulin independence follow...
Léo Bertrand,Alexander V Chervonsky,Agnès Lehuen Léo Bertrand
Type 1 diabetes (T1D) results from the destruction of pancreatic β cells by the immune system, to which both pancreatic β-cell dysfunction and pathological activation of the immune system contribute. This paper is focused on understanding...
Zoe Quandt,Ana Perdigoto,Mark S Anderson et al. Zoe Quandt et al.
Immunomodulatory agents targeting immune checkpoints are now the state-of-the-art for the treatment of many cancers, but at the same time have led to autoimmune side effects, including autoimmune diabetes: immune checkpoint inhibitor-induce...
Anil Bhushan,Peter J Thompson Anil Bhushan
Recent years have seen increased recognition for the role of β-cell stress as a contributing factor to the autoimmune destruction process that ultimately results in symptomatic type 1 diabetes (T1D). Preclinical studies have discovered a v...
Fatoumata Samassa,Capucine Holtzmann,Roberto Mallone Fatoumata Samassa
Type 1 diabetes (T1D) is a disease whose pathogenesis is driven by both immune dysregulation and β-cell dysfunction. While the specialized structure and function of β cells make them vulnerable to autoimmunity, several surface receptor/li...